Cambridge Investment Research Advisors
RETA

Cambridge Investment Research Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Cambridge Investment Research Advisors’s Portfolio RETA Stock Details RETA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
2023
Q2 		$223K Buy
2021
Q4 		– Sell
2021
Q3 		$240K Buy
2021
Q2 		$325K Buy
2021
Q1 		$222K Buy
2020
Q4 		$265K Sell
2020
Q3 		$228K Sell
2020
Q2 		$389K Hold
2020
Q1 		$360K Buy
2019
Q4 		$500K Buy